Comparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells
Authors:
- Gabriela XavierGXGabriela Xavier
- Alexander Navarrete SantosASAlexander Navarrete Santos
- Carla HartmannCHCarla Hartmann
- Marcos L. SantoroMSMarcos L. Santoro
- Nicole FlegelNFNicole Flegel
- Jessica ReinschJRJessica Reinsch
- Annika MajerAMAnnika Majer
- Toni EhrhardtTEToni Ehrhardt
- Jenny PfeiferJPJenny Pfeifer
- Andreas SimmASAndreas Simm
- Thomas HollemannThomas Hollemann
- Sintia I. BelangeroSBSintia I. Belangero
Open Access
- 22 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3575
Abstract
The pathophysiology of many neuropsychiatric disorders is still poorly understood. Identification of biomarkers for these diseases could benefit patients due to better classification and stratification. Exosomes excreted into the circulatory system can cross the blood–brain barrier and carry a cell type-specific set of molecules. Thus, exosomes are a source of potential biomarkers for many diseases, including neuropsychiatric disorders. Here, we investigated exosomal proteins produced from human-induced pluripotent stem cells (iPSCs) and iPSC-derived neural stem cells, neural progenitors, neurons, astrocytes, microglia-like cells, and brain capillary endothelial cells. Of the 31 exosome surface markers analyzed, a subset of biomarkers were significantly enriched in astrocytes (CD29, CD44, and CD49e), microglia-like cells (CD44), and neural stem cells (SSEA4). To identify molecular fingerprints associated with disease, circulating exosomes derived from healthy control (HC) individuals were compared against schizophrenia (SCZ) patients and late-onset Alzheimer’s disease (LOAD) patients. A significant epitope pattern was identified for LOAD (CD1c and CD2) but not for SCZ compared to HC. Thus, analysis of cell type- and disease-specific exosome signatures of iPSC-derived cell cultures may provide a valuable model system to explore proteomic biomarkers for the identification of novel disease profiles.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (270489335, 2018/26241-8)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (270489335, 2018/26241-8)
This publication has 49 references indexed in Scilit:
- Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell PlasticityMolecular Neurobiology, 2023
- When glia meet induced pluripotent stem cells (iPSCs)Molecular and Cellular Neuroscience, 2020
- Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development?Current Protocols in Stem Cell Biology, 2020
- Association of CD14-260 (-159) C/T and Alzheimer’s disease: systematic review and trial sequential analysesJournal of Neural Transmission, 2018
- Translational medicine: from disease- and patient-specific stem cell research to clinical trials and back againEuropean Archives of Psychiatry and Clinical Neuroscience, 2016
- Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- Novel evidence for enhanced stem cell trafficking in antipsychotic-naïve subjects during their first psychotic episodeJournal of Psychiatric Research, 2014
- Integrins and dystroglycan regulate astrocyte wound healing: The integrin β1 subunit is necessary for process extension and orienting the microtubular networkDevelopmental Neurobiology, 2008
- NCAM1 and Neurocognition in SchizophreniaBiological Psychiatry, 2007
- In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133Journal of Neuroscience Research, 2006